NO300016B1 - Karboksyvinylpolymer som har newtonsk viskositet, fremgangsmåte for fremstilling av denne, oftalmiske preparater og bærer for disse - Google Patents
Karboksyvinylpolymer som har newtonsk viskositet, fremgangsmåte for fremstilling av denne, oftalmiske preparater og bærer for disse Download PDFInfo
- Publication number
- NO300016B1 NO300016B1 NO924774A NO924774A NO300016B1 NO 300016 B1 NO300016 B1 NO 300016B1 NO 924774 A NO924774 A NO 924774A NO 924774 A NO924774 A NO 924774A NO 300016 B1 NO300016 B1 NO 300016B1
- Authority
- NO
- Norway
- Prior art keywords
- carboxyvinyl polymer
- viscosity
- cvp
- preparation
- aqueous solution
- Prior art date
Links
- 229920002125 Sokalan® Polymers 0.000 title claims description 73
- 238000002360 preparation method Methods 0.000 title claims description 58
- 238000000034 method Methods 0.000 title claims description 13
- 239000000969 carrier Substances 0.000 title 1
- 239000007864 aqueous solution Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000010008 shearing Methods 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003431 cross linking reagent Substances 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 150000001993 dienes Chemical class 0.000 claims description 2
- KUQWZSZYIQGTHT-UHFFFAOYSA-N hexa-1,5-diene-3,4-diol Chemical compound C=CC(O)C(O)C=C KUQWZSZYIQGTHT-UHFFFAOYSA-N 0.000 claims description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 229940126601 medicinal product Drugs 0.000 claims 1
- 229940059574 pentaerithrityl Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 19
- 239000003814 drug Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 230000035699 permeability Effects 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000013068 control sample Substances 0.000 description 4
- 229960002143 fluorescein Drugs 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000001742 aqueous humor Anatomy 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001437 anti-cataract Effects 0.000 description 1
- 230000001384 anti-glaucoma Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 1
- VQODGRNSFPNSQE-DVTGEIKXSA-N betamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-DVTGEIKXSA-N 0.000 description 1
- 229950006991 betamethasone phosphate Drugs 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940054534 ophthalmic solution Drugs 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- -1 pharmaceutical Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33091091 | 1991-12-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO924774D0 NO924774D0 (no) | 1992-12-10 |
| NO924774L NO924774L (no) | 1993-06-14 |
| NO300016B1 true NO300016B1 (no) | 1997-03-17 |
Family
ID=18237851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO924774A NO300016B1 (no) | 1991-12-13 | 1992-12-10 | Karboksyvinylpolymer som har newtonsk viskositet, fremgangsmåte for fremstilling av denne, oftalmiske preparater og bærer for disse |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5458873A (da) |
| EP (1) | EP0546810B1 (da) |
| JP (2) | JP2873530B2 (da) |
| KR (1) | KR100233473B1 (da) |
| CN (1) | CN1074224A (da) |
| AT (1) | ATE148724T1 (da) |
| CA (1) | CA2085149A1 (da) |
| DE (1) | DE69217338T2 (da) |
| DK (1) | DK0546810T3 (da) |
| ES (1) | ES2097887T3 (da) |
| FI (1) | FI925649A (da) |
| NO (1) | NO300016B1 (da) |
| TW (1) | TW305848B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| FR2717691B1 (fr) * | 1994-03-22 | 1998-02-13 | Europhta Laboratoire | Nouveaux gels ophtalmiques et leur procédé d'obtention. |
| US5683993A (en) * | 1995-06-22 | 1997-11-04 | Ciba Vision Corporation | Compositions and methods for stabilizing polymers |
| FR2742336B1 (fr) * | 1995-12-19 | 1998-03-06 | Chauvin Lab Sa | Collyre destine notamment au traitement de l'oeil sec |
| JP2001158750A (ja) * | 1999-12-02 | 2001-06-12 | Lion Corp | 眼科用組成物及び抗アレルギー薬の持続性向上方法 |
| KR20040023740A (ko) | 2001-08-10 | 2004-03-18 | 도레이 가부시끼가이샤 | 다당류 함유 조성물 및 그의 용도 |
| US20080199524A1 (en) * | 2001-08-10 | 2008-08-21 | Toray Industries, Inc. | Eyedrops containing particulate agar |
| EP1683528A4 (en) * | 2003-11-10 | 2011-07-27 | Toray Industries | POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM |
| KR100775065B1 (ko) | 2006-06-13 | 2007-11-08 | 주식회사태준제약 | 효과 지속형 점안제 조성물 및 이의 제조방법 |
| WO2008077712A1 (en) * | 2006-12-22 | 2008-07-03 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Gel useful for the delivery of ophthalmic drugs |
| US10201548B2 (en) * | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| US10980818B2 (en) | 2009-03-06 | 2021-04-20 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| IT1393419B1 (it) * | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
| TWI489997B (zh) * | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸－多元醇錯合物之水性藥學組成物 |
| JP4777477B2 (ja) | 2009-09-30 | 2011-09-21 | ロート製薬株式会社 | 点眼剤 |
| DE102012218814A1 (de) * | 2012-10-16 | 2014-04-17 | Robert Bosch Gmbh | Verfahren zur Bestimmung der Homogenität einer Formulierung |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3649358A (en) * | 1968-12-23 | 1972-03-14 | Ibm | Method for reducing the viscosity of non-newtonian liquids by the use of ultrasonics |
| US3884826A (en) * | 1973-07-20 | 1975-05-20 | Barnes Hind Pharm Inc | Thixotropic cleaning agent for hard contact lenses |
| GB1468598A (en) * | 1974-05-01 | 1977-03-30 | Australia Res Lab | Method of and means for image development in electrostatic printing |
| JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
| GB2013084B (en) * | 1978-01-25 | 1982-07-28 | Alcon Lab Inc | Ophthalmic drug dosage |
| ATE6466T1 (de) * | 1979-10-26 | 1984-03-15 | Smith And Nephew Associated Companies P.L.C. | Autoklavierbare emulsionen. |
| JPS60235815A (ja) * | 1984-05-08 | 1985-11-22 | Sansui Kk | 水性組成物用ｐＨ感応性増粘剤 |
| US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| JPS6343930A (ja) * | 1986-08-11 | 1988-02-25 | Mitsubishi Petrochem Co Ltd | 高吸水性ポリマ−の製造法 |
| IL80298A (en) * | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| IE63392B1 (en) * | 1988-02-08 | 1995-04-19 | Insite Vision Inc | Ophthalmic suspensions |
| US5192535A (en) * | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
-
1992
- 1992-12-04 JP JP4325171A patent/JP2873530B2/ja not_active Expired - Fee Related
- 1992-12-07 US US07/986,284 patent/US5458873A/en not_active Expired - Fee Related
- 1992-12-09 DK DK92311208.0T patent/DK0546810T3/da active
- 1992-12-09 AT AT92311208T patent/ATE148724T1/de not_active IP Right Cessation
- 1992-12-09 ES ES92311208T patent/ES2097887T3/es not_active Expired - Lifetime
- 1992-12-09 DE DE69217338T patent/DE69217338T2/de not_active Expired - Fee Related
- 1992-12-09 EP EP92311208A patent/EP0546810B1/en not_active Expired - Lifetime
- 1992-12-10 NO NO924774A patent/NO300016B1/no not_active IP Right Cessation
- 1992-12-11 KR KR1019920023926A patent/KR100233473B1/ko not_active IP Right Cessation
- 1992-12-11 CA CA002085149A patent/CA2085149A1/en not_active Abandoned
- 1992-12-11 TW TW081109936A patent/TW305848B/zh active
- 1992-12-11 FI FI925649A patent/FI925649A/fi not_active IP Right Cessation
- 1992-12-12 CN CN92114432.6A patent/CN1074224A/zh not_active Withdrawn
-
1998
- 1998-08-20 JP JP10233842A patent/JPH11130661A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1074224A (zh) | 1993-07-14 |
| EP0546810A1 (en) | 1993-06-16 |
| ATE148724T1 (de) | 1997-02-15 |
| JPH05247308A (ja) | 1993-09-24 |
| NO924774L (no) | 1993-06-14 |
| EP0546810B1 (en) | 1997-02-05 |
| DE69217338D1 (de) | 1997-03-20 |
| CA2085149A1 (en) | 1993-06-14 |
| TW305848B (da) | 1997-05-21 |
| JP2873530B2 (ja) | 1999-03-24 |
| DE69217338T2 (de) | 1997-05-28 |
| US5458873A (en) | 1995-10-17 |
| KR100233473B1 (ko) | 1999-12-01 |
| FI925649A0 (fi) | 1992-12-11 |
| DK0546810T3 (da) | 1997-08-18 |
| NO924774D0 (no) | 1992-12-10 |
| FI925649A (fi) | 1993-06-14 |
| ES2097887T3 (es) | 1997-04-16 |
| JPH11130661A (ja) | 1999-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO300016B1 (no) | Karboksyvinylpolymer som har newtonsk viskositet, fremgangsmåte for fremstilling av denne, oftalmiske preparater og bærer for disse | |
| US4188373A (en) | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes | |
| DK167344B1 (da) | Topisk ophthalmisk laegemiddel samt fremgangsmaade til fremstilling af dette | |
| US4100271A (en) | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes | |
| DE60131088T2 (de) | Gelierende wässrige pharmazeutische zusammensetzungen | |
| Camber et al. | Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits | |
| JPH08506588A (ja) | アルカリ性眼科用懸濁液剤 | |
| CA2289618A1 (en) | Aqueous suspension preparations with excellent redispersibility | |
| Dubey et al. | Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma | |
| KR100927067B1 (ko) | 퀴놀론 카르복실산 조성물 및 이와 관련된 치료 방법 | |
| US10653783B2 (en) | Sustained release of bioactive factors from zwitterionic hydrogels | |
| US5292517A (en) | pH sensitive, reversible gelling, copolymeric erodible drug delivery system | |
| MX2010009857A (es) | Composicion oftalmica. | |
| KR20160060227A (ko) | 안과 질환 예방 또는 치료용 조성물 | |
| KR20140069210A (ko) | 안과적 겔 조성물 | |
| JPH05170643A (ja) | 水性目薬及びその製造法 | |
| JP3269770B2 (ja) | 再分散性の優れたイオン性高分子配合水性懸濁点眼剤 | |
| BRPI0215189B1 (pt) | composição viscoelástica aquosa, estéril, para uso em procedimentos cirúrgicos oftálmicos | |
| Panchal et al. | Development and evaluation ophthalmic in situ gel of betaxolol HCl by temperature dependent method for treatment of glaucoma | |
| KR20100129263A (ko) | 다당류 미립자상 겔 함유 수분산체 및 그 제조 방법 | |
| EP3675872B1 (en) | Compositions providing improved eye comfort | |
| Makhmalzadeh et al. | Loratadine-loaded thermoresponsive hydrogel: characterization and ex-vivo rabbit cornea permeability studies | |
| CN109200016A (zh) | 一种苄达赖氨酸滴眼液及其制备方法与用途 | |
| Dumitriu et al. | Bioactive polymers XXXIX. Retarded ophthalmic drugs base on pilocarpine and xanthan derivatives | |
| Manasa et al. | FORMULATION AND EVALUATION OF MOXIFLOXACIN OCULAR MICROEMULSION GEL |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |